Addiction Medication Shows Promise for Long COVID Recovery
Summary: Researchers have identified a promising approach to treat long COVID by restoring ion channel function in immune cells using low-dose naltrexone. Published in Frontiers in Immunology and led by Griffith University’s National Centre for Neuroimmunology and Emerging Diseases (NCNED), the finding mirrors earlier work in myalgic encephalomyelitis/chronic fatigue syndrome (ME/CFS) and suggests a shared … Read more